<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/B/Bevacizumab.html">
<title>Bevacizumab RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/B/Bevacizumab.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2012-02-09T09:24+31:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Bevacizumab RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/VEGFRSSfeeds/statuses/167582856548331520" />
  <rdf:li rdf:resource="http://twitter.com/criscancer/statuses/167568722217803779" />
  <rdf:li rdf:resource="http://twitter.com/mightyshealth/statuses/167523997330845697" />
  <rdf:li rdf:resource="http://twitter.com/ugcfarmacg/statuses/167521647874678784" />
  <rdf:li rdf:resource="http://twitter.com/emiliomonteb/statuses/167506616772591617" />
  <rdf:li rdf:resource="http://twitter.com/luismagaldi/statuses/167428134310907906" />
  <rdf:li rdf:resource="http://twitter.com/MDLinx/statuses/167408802646343683" />
  <rdf:li rdf:resource="http://twitter.com/laurenwestie/statuses/167346080030261249" />
  <rdf:li rdf:resource="http://twitter.com/livedoctorchat/statuses/167300471818698753" />
  <rdf:li rdf:resource="http://twitter.com/NurseForHealth/statuses/167293295804944384" />
  <rdf:li rdf:resource="http://twitter.com/FWaisen/statuses/167286977425711104" />
  <rdf:li rdf:resource="http://twitter.com/MDLinx/statuses/167225809302597632" />
  <rdf:li rdf:resource="http://twitter.com/MDLinx/statuses/167225034782412802" />
  <rdf:li rdf:resource="http://twitter.com/OncologyAdvance/statuses/167216960193576960" />
  <rdf:li rdf:resource="http://twitter.com/_DMAE_/statuses/167200663607062529" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/VEGFRSSfeeds/statuses/167582856548331520">
<title>[VEGF] Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon ca... http://t.co/QWBAGjyu PM</title>
<link>http://twitter.com/VEGFRSSfeeds/statuses/167582856548331520</link>
<description><![CDATA[[VEGF] Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon ca... http://t.co/QWBAGjyu PM]]></description>
</item>

<item rdf:about="http://twitter.com/criscancer/statuses/167568722217803779">
<title>El f&#xC3;&#xA1;rmaco dirigido bevacizumab (Avastin) prolonga el tiempo que las mujeres con c&#xC3;&#xA1;ncer de ovario avanzado viven... http://t.co/lnDED8uq</title>
<link>http://twitter.com/criscancer/statuses/167568722217803779</link>
<description><![CDATA[El fármaco dirigido bevacizumab (Avastin) prolonga el tiempo que las mujeres con cáncer de ovario avanzado viven... http://t.co/lnDED8uq]]></description>
</item>

<item rdf:about="http://twitter.com/mightyshealth/statuses/167523997330845697">
<title>AntiVEGF Antibody Bevacizumab Avastin #VascularEndothelial: The most successful approach to&#xE2;&#x80;&#xA6; http://t.co/lQPfHzbF</title>
<link>http://twitter.com/mightyshealth/statuses/167523997330845697</link>
<description><![CDATA[AntiVEGF Antibody Bevacizumab Avastin #VascularEndothelial: The most successful approach to… http://t.co/lQPfHzbF]]></description>
</item>

<item rdf:about="http://twitter.com/ugcfarmacg/statuses/167521647874678784">
<title>RT@emiliomonteb
Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration http://t.co/XX6z3F3R</title>
<link>http://twitter.com/ugcfarmacg/statuses/167521647874678784</link>
<description><![CDATA[RT@emiliomonteb
Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration http://t.co/XX6z3F3R]]></description>
</item>

<item rdf:about="http://twitter.com/emiliomonteb/statuses/167506616772591617">
<title>Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration http://t.co/ISuU6fgK</title>
<link>http://twitter.com/emiliomonteb/statuses/167506616772591617</link>
<description><![CDATA[Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration http://t.co/ISuU6fgK]]></description>
</item>

<item rdf:about="http://twitter.com/luismagaldi/statuses/167428134310907906">
<title>El bevacizumab podr&#xC3;&#xAD;a beneficiar a algunas mujeres con c&#xC3;&#xA1;ncer de ovario. Instituto Nacional del C&#xC3;&#xA1;ncer. http://t.co/uH6bkjU7 via @AddThis</title>
<link>http://twitter.com/luismagaldi/statuses/167428134310907906</link>
<description><![CDATA[El bevacizumab podría beneficiar a algunas mujeres con cáncer de ovario. Instituto Nacional del Cáncer. http://t.co/uH6bkjU7 via @AddThis]]></description>
</item>

<item rdf:about="http://twitter.com/MDLinx/statuses/167408802646343683">
<title>Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy ... http://t.co/lpyin9is #GI</title>
<link>http://twitter.com/MDLinx/statuses/167408802646343683</link>
<description><![CDATA[Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy ... http://t.co/lpyin9is #GI]]></description>
</item>

<item rdf:about="http://twitter.com/laurenwestie/statuses/167346080030261249">
<title>@jeyaramb the use of bevacizumab in treating ovarian cancer! you? x</title>
<link>http://twitter.com/laurenwestie/statuses/167346080030261249</link>
<description><![CDATA[@jeyaramb the use of bevacizumab in treating ovarian cancer! you? x]]></description>
</item>

<item rdf:about="http://twitter.com/livedoctorchat/statuses/167300471818698753">
<title>livechatwithdoctorco Bevacizumab (Avastin) and Ovarian Cancer: Bevacizumab (Avastin) and Ovarian Cancer

By:  An... http://t.co/nwqtXjm1</title>
<link>http://twitter.com/livedoctorchat/statuses/167300471818698753</link>
<description><![CDATA[livechatwithdoctorco Bevacizumab (Avastin) and Ovarian Cancer: Bevacizumab (Avastin) and Ovarian Cancer

By:  An... http://t.co/nwqtXjm1]]></description>
</item>

<item rdf:about="http://twitter.com/NurseForHealth/statuses/167293295804944384">
<title>When Combined with Chemotherapy, Bevacizumab Is Associated with Increased Risk of Death http://t.co/XJ5fNGTV</title>
<link>http://twitter.com/NurseForHealth/statuses/167293295804944384</link>
<description><![CDATA[When Combined with Chemotherapy, Bevacizumab Is Associated with Increased Risk of Death http://t.co/XJ5fNGTV]]></description>
</item>

<item rdf:about="http://twitter.com/FWaisen/statuses/167286977425711104">
<title>Seguridad de las inyecciones de avastin (bevacizumab) en retinopat&#xC3;&#xAD;a del prematuro. http://t.co/u8QzEYPw v&#xC3;&#xAD;a @oftvirgendelmar</title>
<link>http://twitter.com/FWaisen/statuses/167286977425711104</link>
<description><![CDATA[Seguridad de las inyecciones de avastin (bevacizumab) en retinopatía del prematuro. http://t.co/u8QzEYPw vía @oftvirgendelmar]]></description>
</item>

<item rdf:about="http://twitter.com/MDLinx/statuses/167225809302597632">
<title>Bevacizumab nasal spray: non-invasive treatment of epistaxis in patients with Rendu-Osler disease: The Lary... http://t.co/k06ljg4n #ENT</title>
<link>http://twitter.com/MDLinx/statuses/167225809302597632</link>
<description><![CDATA[Bevacizumab nasal spray: non-invasive treatment of epistaxis in patients with Rendu-Osler disease: The Lary... http://t.co/k06ljg4n #ENT]]></description>
</item>

<item rdf:about="http://twitter.com/MDLinx/statuses/167225034782412802">
<title>Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: Fina... http://t.co/IdMBiLnc #GI</title>
<link>http://twitter.com/MDLinx/statuses/167225034782412802</link>
<description><![CDATA[Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: Fina... http://t.co/IdMBiLnc #GI]]></description>
</item>

<item rdf:about="http://twitter.com/OncologyAdvance/statuses/167216960193576960">
<title>Incidence of Bevacizumab-Related Bleeding Events in NSCLC - published in Lung Cancer. Free at http://t.co/biIzQJgK</title>
<link>http://twitter.com/OncologyAdvance/statuses/167216960193576960</link>
<description><![CDATA[Incidence of Bevacizumab-Related Bleeding Events in NSCLC - published in Lung Cancer. Free at http://t.co/biIzQJgK]]></description>
</item>

<item rdf:about="http://twitter.com/_DMAE_/statuses/167200663607062529">
<title>RT @joaquinfdezoft: Seguridad de las inyecciones de avastin en retinopat&#xC3;&#xAD;a del prematuro http://t.co/0craa7un</title>
<link>http://twitter.com/_DMAE_/statuses/167200663607062529</link>
<description><![CDATA[RT @joaquinfdezoft: Seguridad de las inyecciones de avastin en retinopatía del prematuro http://t.co/0craa7un]]></description>
</item>

</rdf:RDF>
